Ekocorp

Ekocorp Financing Cash Flow

The Net Financing Cash Flow of Ekocorp (EKOCORP.NL) as of Oct 22, 2026 is 387.91 M NGN. In the previous year, Net Financing Cash Flow was 387.91 M NGN — a change of 0.00% (lower).

Financing Cash Flow

387.91 MNGN

YoY

0.00%

Last updated:

Net Financing Cash Flow of Ekocorp is 2020 387.91 M NGN. Net Financing Cash Flow of Ekocorp was 2019 387.91 M NGN. It decreases by 0.00% lower compared to the previous year.

The Ekocorp Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2015
722.39 M NGN
Jan 1, 2016
-8.09 M NGN
Jan 1, 2017
-2.75 M NGN
Jan 1, 2018
21.68 M NGN
Jan 1, 2019
387.91 M NGN
Jan 1, 2020
387.91 M NGN
The Ekocorp Financing Cash Flow history
YEARFinancing Cash FlowYoY
387.91 MNGN0.00%
387.91 MNGN+1,689.58%
21.68 MNGN-889.37%
-2.75 MNGN-66.06%
-8.09 MNGN-101.12%
722.39 MNGN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ekocorp Stock analysis

What does Ekocorp do? Ekocorp PLC provides healthcare services through its segments including standalone facilities, capitation models, and strategic business units such as general outpatients, nursing, intensive care, medical, obstetrics and gynaecology, paediatrics, radiology, and surgery. The company offers specialized medical services like dietician, diabetic nurse educator, foot care specialist, and consultant ophthalmologist. Its consultant services encompass general surgery, orthopaedic surgery, grammatology, otorhinolaryngology, audiology, speech therapy, dental surgery, ophthalmology, radiology, physical medicine (Physiotherapy), endoscopy, anaesthesia, obstetrics and gynaecology, radiotherapy, and oncology. Ekocorp also provides immunological screening services including thyroid antibodies, thyroid adrenal anti-nuclear antibodies, and paediatric endocrinology. The firm targets patients seeking specialized medical care and preventive health services. Its services are delivered through its healthcare delivery model focused on standard medical care and anchor services. Ekocorp's strategic business units serve diverse patient needs across various medical specialties. The company's offerings include both outpatient and inpatient care through its structured segments. Ekocorp PLC's revenue streams come from medical service fees charged to patients and healthcare providers. The company generates income through its consultant services, specialized medical care, and immunological screening services. Its business model relies on delivering high-quality healthcare services across multiple specialties to a broad patient base. The firm's segments operate under a unified healthcare delivery framework that supports its service offerings. Ekocorp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ekocorp stock

Net Financing Cash Flow of Ekocorp is 387.91 M NGN in 2020.

Net Financing Cash Flow of Ekocorp changed from 387.91 M NGN to 387.91 M NGN, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Financing Cash Flow Ekocorp since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's NGN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's Ekocorp historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Ekocorp

All Key Metrics — Ekocorp